chemotherapy-induced mucositis


Also found in: Wikipedia.

chemotherapy-induced mucositis

Oral inflammation caused by medications, esp. those used to treat cancers or autoimmune diseases.

Patient care

Mucositis may alter a person's ability to brush his teeth, drink fluids, eat foods, sleep, or talk comfortably. If the patient has severe, painful sores, he may need a feeding tube for hydration and nutrition.

See also: mucositis
References in periodicals archive ?
Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis.
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
Abimosleh said that disorders of the gastrointestinal tract, like inflammatory bowel diseases and chemotherapy-induced mucositis, are associated with malabsorption of food together with inflammation and ulceration of the bowel lining.
Light-Emitting Diode Therapy in Chemotherapy-Induced Mucositis.
It has shown remarkable efficacy in preclinical animal models of NEC and intestinal ischemia/reperfusion injury, and may have additional utility in the treatment of other intestinal disorders, such as short bowel syndrome, inflammatory bowel disease and chemotherapy-induced mucositis.
The company said it has shown "remarkable efficacy" in preclinical animal models of NEC and intestinal ischemia/reperfusion injury, and may have additional utility in the treatment of other intestinal disorders, such as short bowel syndrome, inflammatory bowel disease and chemotherapy-induced mucositis.
Nuvelo is also progressing its preclinical development candidate, NU206, for the potential treatment of radiation and chemotherapy-induced mucositis in the gastrointestinal tract.
Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study.
Products currently in clinical trials include MPIF-1, a drug that may improve treatments with a number of cancer chemotherapies, and KGF-2 for the treatment of venous ulcers and chemotherapy-induced mucositis.
If Protegrin IB-367 can safely reduce the severity and duration of chemotherapy-induced mucositis as was suggested by the results of animal studies reported at the recent Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), it could provide significant health and economic benefits.
The researchers also tested the recombinant protein in an animal model of chemotherapy-induced mucositis.
Full browser ?